Gerald P Murphy masthead

Cancer Biology

Chiang EC, Shen S, Kengeri SS, Xu H, Combs GF Jr., Morris SJ, Bostwick DG, Waters DJ. Defining the optimal selenium dose for prostate cancer risk reduction: Insights from the U-shaped relationship between selenium status, DNA damage, and apoptosis. Dose-Response e-pub 21 December 2009.

Waters DJ, Chiang EC, Bostwick DG. The art of casting nets: fishing for the prize of personalized cancer prevention. Nutr Cancer 2008; 60:1-6.

Waters DJ, Wildasin K. Cancer clues from pet dogs. Scientific American 2006; 295: 94-101.

Hay RV, Cao B, Skinner RS, Su Y, Zhao P, Gustafson MF, Qian CN, Teh BT, Knudsen BS, Resau JH, Shen S, Waters DJ, Gross MD, Vande Woude GF. Nuclear imaging of Met-expressing human and canine cancer xenografts with radiolabeled monoclonal antibodies (MetSeek). Clin Cancer Res. 2005; 11:7064s-7069s.

Shinomiya N, Gao CF, Xie Q, Gustafson M, Waters DJ, Zhang YW, Vande Woude GF. RNA interference reveals that ligand-independent met activity is required for tumor cell signaling and survival. Cancer Res 2004; 64:7962-7970.

Cooley DM, Schlittler DL, Glickman LT, Hayek M, Waters DJ. Exceptional longevity in pet dogs is accompanied by cancer resistance and delayed onset of major diseases. J Gerontol Biol Sci 2003;58:B1078-1084.

Mohammed SI, Coffman K, Glickman NW, Hayek MG, Waters DJ, Schlittler D, DeNicola DB, Knapp DW. Prostaglandin E2 concentrations in naturally occurring canine cancer. Prostaglandins Leukotrienes Essential Fatty Acids 2001; 64:1-4.

Cornell K and Waters DJ. Impaired wound healing in the cancer patient: effects of cytotoxic therapy and pharmacologic modulation by growth factors. Vet Clinics N America 1995; 25:111-131.

Waters DJ. Tumor metastasis: current biological concepts and their implications for control of residual disease. Vet Clinics N America 1995; 25:231-247.